DEVELOPMENT OF NOVEL MONOCLONAL ANTIBODIES AND LONGITUDINAL STUDY OF IMMUNE RESPONSES USING SERUM AND PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC’s) OF INFECTIOUS DISEASE SURVIVORS
Award Notice Posted
- Solicitation number
- W81XWH-21-R-0074
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Awarded
- to Integrum Scientific LLC
- Set-aside
- Total Small Business
Opportunity facts
- Contract number
- W81XWH-21-C-0113 Federal contract award
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Frederick, Maryland 21702, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of the Army Medical Command awarded a contract valued at $2,940,845 to Integrum Scientific, LLC on September 17, 2021. The contract is for the development of novel monoclonal antibodies and a longitudinal study of immune responses using serum and peripheral blood mononuclear cells from survivors of infectious diseases.
Notice text
Awarded contract W81XWH-21-C-0113 to Integrum Scientific, LLC for 2940845.00 on 2021-09-17.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| DEVELOPMENT OF NOVEL MONOCLONAL ANTIBODIES AND LONGITUDINAL STUDY OF IMMUNE RESPONSES USING SERUM AND PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC’s) OF INFECTIOUS DISEASE SURVIVORS | Solicitation | |
| GeneMapper ID-X | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity